| Discovery Fine Chemicals Ltd. | UK | Inquire | ||
|---|---|---|---|---|
![]() |
+44 (1202) 874-517 | |||
![]() |
pjc@discofinechem.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2009 | ||||
| SL Drugs and Pharmaceuticals Pvt. Ltd. | India | Inquire | ||
|---|---|---|---|---|
![]() |
+91 (40) 6661-1133 | |||
![]() |
enquiry@sldrugs.com | |||
| Chemical distributor since 1999 | ||||
| chemBlink standard supplier since 2010 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Glentham Life Sciences | UK | Inquire | ||
|---|---|---|---|---|
![]() |
+44 (2033) 978-798 | |||
![]() |
info@glenthamls.com | |||
| Chemical distributor since 2013 | ||||
| chemBlink standard supplier since 2013 | ||||
| Carbosynth China Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (512) 6260-5585 | |||
![]() |
sales@carbosynth.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink standard supplier since 2016 | ||||
| Chengdu Biopurify Phytochemicals Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (28) 8263-3860 8263-3987 | |||
![]() |
sales@biopurify.com biopurify@gmail.com | |||
![]() |
Skype Chat | |||
![]() |
QQ chat | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2017 | ||||
| Guilin Qihong Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 13132738337 | |||
![]() |
online@qh-tech.cn | |||
| Chemical manufacturer since 2016 | ||||
| chemBlink standard supplier since 2025 | ||||
| Classification | Biochemical >> Inhibitor >> Stem cells & wnt signaling paths (Stem cells & wnt) |
|---|---|
| Name | Gossypin |
| Synonyms | Gossypetin 8-glucoside; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one |
| Molecular Structure | ![]() |
| Molecular Formula | C21H20O13 |
| Molecular Weight | 480.38 |
| CAS Registry Number | 652-78-8 |
| EC Number | 613-767-7 |
| SMILES | C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C(=C(C=C3O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O |
| Solubility | Slightly soluble (1.7 g/L) (25 ºC), Calc.* |
|---|---|
| Density | 1.883±0.06 g/cm3 (20 ºC 760 Torr), Calc.* |
| Melting point | 230 ºC (dec.)** |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2013 ACD/Labs) |
| ** | Neelakantam, K.; Proceedings - Indian Academy of Sciences, Section A 1936, V4A, P54-8. |
| Hazard Symbols |
| ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Statements | H315-H319-H335 Details | ||||||||||||||||||||
| Precautionary Statements | P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501 Details | ||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||
| |||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||
|
Gossypin is a naturally occurring flavonoid compound classified as a flavonol glycoside. It is chemically characterized as 3,5,7,3′,4′,5′-hexahydroxyflavone 8-O-glucoside, with the molecular formula C21H20O13. Gossypin is primarily found in plants belonging to the *Hibiscus* and *Gossypium* genera, particularly in the flowers of *Hibiscus vitifolius*. As a member of the flavonoid family, gossypin has attracted scientific interest for its biological properties and potential therapeutic applications. The compound was first isolated in the mid-20th century during investigations of plant constituents with potential medicinal value. Phytochemical studies of *Hibiscus vitifolius* and related species revealed gossypin as one of the key flavonoids present in the petals and other aerial parts. Its structure was determined through a combination of chemical degradation, spectroscopic analysis, and chromatography, confirming the presence of multiple hydroxyl groups and a glucose moiety. Gossypin has been extensively studied in experimental settings for a range of biological activities. One of its most documented properties is its antioxidant capacity. The compound exhibits strong free radical scavenging ability due to its polyhydroxylated structure, which allows it to donate electrons or hydrogen atoms to reactive oxygen species. This property has been examined in vitro and in vivo for its protective effects against oxidative stress in cellular systems. In addition to its antioxidant activity, gossypin has shown anti-inflammatory effects in laboratory studies. It modulates the production of pro-inflammatory cytokines and enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), thereby attenuating inflammatory responses. These properties have been observed in animal models of inflammation, where gossypin administration resulted in reduced edema and tissue damage. Gossypin has also been explored for its potential anticancer properties. Research has demonstrated that it can inhibit the proliferation of various cancer cell lines, including those from colon, breast, and liver cancers. The mechanisms proposed for these effects include the induction of apoptosis, inhibition of cell cycle progression, and modulation of signaling pathways involved in cell growth and survival. These findings are limited to preclinical studies, and gossypin has not been developed as an approved anticancer agent. Other areas of research involving gossypin include its possible antidiabetic effects, hepatoprotective activity, and neuroprotective potential. In experimental models of diabetes, gossypin has been reported to lower blood glucose levels and improve insulin sensitivity. It has also been shown to protect liver tissue from chemically induced damage and reduce markers of liver toxicity. Neuroprotective studies suggest that gossypin may help mitigate neuronal damage under oxidative stress conditions, although these findings remain preliminary. Despite these varied effects, gossypin has not been developed into a pharmaceutical drug. Its poor water solubility and low oral bioavailability pose challenges for formulation and systemic delivery. Ongoing research includes the synthesis of gossypin derivatives and development of nanoparticle-based delivery systems to enhance its pharmacological utility. Gossypin is also studied in the context of traditional medicine. Plants containing gossypin have been used in folk remedies for their purported health benefits, including wound healing and fever reduction. However, these uses are not standardized, and clinical evidence supporting them is lacking. In summary, gossypin is a flavonol glycoside isolated from species in the *Hibiscus* and *Gossypium* genera. It has been studied for its antioxidant, anti-inflammatory, anticancer, and other biological properties in experimental models. While its therapeutic potential remains under investigation, gossypin continues to serve as a useful compound in pharmacological and phytochemical research. References 2024. Exploring polyphenolic profiles by using a multivariate approach in Citrullus colocynthis (L.) Schrad. Discover Applied Sciences, 6(10). DOI: 10.1007/s42452-024-06205-5 2024. A comprehensive tool in recycling plant-waste of Gossypium barbadense L agricultural and industrial waste extracts containing gossypin and gossypol: hepatoprotective, anti-inflammatory and antioxidant effects. Plant Methods, 20(1). DOI: 10.1186/s13007-024-01181-8 2021. Evaluation of the protective effects of gossypin for ischemia/reperfusion injury in ovary tissue. The Journal of Obstetrics and Gynaecology Research, 47(12). DOI: 10.1111/jog.15127 |
| Market Analysis Reports |
| List of Reports Available for Gossypin |